The Indian government has partly relaxed its restrictions on exports of Remdesivir, an antiviral used in the treatment of COVID-19. Total exports of the drug and its active ingredient were worth $111 million in the 12 months to April 30 and dropped to just $2.7 million in the month of April before the ban, now modified to licensing, was introduced. India’s wider restriction on exports of COVID-19 vaccines remains in place after being imposed in April. Total Indian exports of all vaccines dropped by 36.8% in April versus the Q1’21 average. That was led by a 55.9% slump in shipments linked...